Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients
Palabras clave : 
Materias Investigacion::Ciencias de la Salud::Hepatología
COVID-19
SARS-CoV-2
Pneumonia
Epidemiology
Transplantation
Immunosuppression
Mycophenolate
Calcineurin inhibitors
Tacrolimus
Ever- olimus
Standardised incidence
Standardised mortality
Fecha de publicación : 
2021
Editorial : 
Elsevier
ISSN : 
0168-8278
Cita: 
Colmenero, J. (Jordi); Rodriguez, M. (Manuel); Salcedo, M. (Magdalena); et al. "Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients". Journal of Hepatology. 74, 2021, 148 - 155
Resumen
In liver transplant patients, chronic immunosuppression increases the risk of acquiring COVID-19 but it could reduce disease severity. Com- plete immunosuppression with- drawal may not be justified. However, mycophenolate withdrawal or tem- porary conversion to calcineurin inhibitors or everolimus until disease resolution could be beneficial in hos- pitalised patients.

Ficheros en este ítem:
Fichero
Epidemiological.pdf
Descripción
Tamaño
1.06 MB
Formato
Adobe PDF


Estadísticas e impacto
0 citas en
0 citas en

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.